The results indicate that the conventional agent doxycycline is more active than quinolones and macrolides against the B. melitensis in vitro.
4] . Despite having alternative therapies, treatment of brucellosis is still problematic due to factors such as side effects of some antibiotics, poor compliance of patients, and the high relapse rate with some of the combination regimens [5] .
The purpose of this study was to compare the in vitro susceptibility of clinical isolates of B. melitensis to three quinolones (ciprofl oxacin, levofl oxacin, moxifl oxacin), four macrolides (erythromycin, dirithromycin, azithromycin, clarithromycin) and the conventional agent doxycycline.
Materials and Methods
The study was performed on 44 B. melitensis strains, which were isolated from blood cultures of hospitalized adult patients with acute brucellosis between 1998 and 2003. B. melitensis strains were identifi ed by conventional methods (gram staining, no CO 2 requirement, production of H 2 S, and other biochemical properties). Stocked strains were stored in protect bacterial preservers (Technical Service Consultant Ltd., Lancashire, England) at -80 ° C and were subcultured twice a week prior to the study.
The antibiotics were provided by the following suppliers in powder form: erythromycin (Sigma, Istanbul, Turkey); dirithromycin (Abdi I ˙ brahim I ˙ laç Sanayi ve Ticaret A S ¸ , Istanbul, Turkey); azithromycin and clarithromycin (Adilna Sanovel I ˙ laç Sanayii, Istanbul, Turkey); ciprofl oxacin and moxifl oxacin (Bayer, Istanbul, Turkey); levofl oxacin and doxycycline (Fako I ˙ laçları A S ¸ , Istanbul, Turkey).
The agar dilution method as previously described [6] was used to determine the minimum inhibitory concentrations (MICs) of the antimicrobial agents. Mueller-Hinton agar (Oxoid Ltd., Basingstoke, Hampshire, England) supplemented with 1% hemoglobin (bioMérieux, Lyon, France) and 1% PoliVitex (bioMérieux) was used as the culture medium. The stock solutions of the antibiotics were prepared in 100 ml of sterile distilled water and stored frozen in small volumes, in sterile polypropylene vials at -70 ° C. Serial twofold dilutions of the antimicrobial agents were prepared in Mueller-Hinton broth supplemented with 1% PoliVitex. The concentration range was 0.125-64 g/ml for the macrolides, and 0.03-16 g/ml for the quinolones and doxycycline.
The bacterial inoculum was prepared by suspending smooth B. melitensis strains cultivated in Brucella agar (Difco), in brainheart infusion broth. Following 48 h incubation, the suspensions were adjusted to 0.5 McFarland turbidity to yield a fi nal inoculum of 10 5 -10 6 cfu/ml. The inoculations were made by a multipoint inoculator. Plates were incubated at 35 ° C in ambient conditions. The results were evaluated after 48 h. MIC values were defi ned as the lowest concentration of the antibiotic that completely inhibited growth. MIC 90 and MIC 50 values were defi ned as the lowest concentration of the antibiotic at which 90 and 50% of the isolates were inhibited, respectively. All measurements were performed in duplicate. Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 29213 and plates of Mueller-Hinton agar without antibiotics were used as controls.
Results
The MIC values of the antimicrobial agents studied by the agar dilution method are listed in table 1 . Doxycycline had the lowest MIC in vitro against the B. melitensis strains. Among the quinolones, ciprofl oxacin and levofl oxacin had similar activities (MIC 50 : 0.5 g/ml; MIC 90 : 2 g/ml), whereas the MIC of moxifl oxacin (MIC 50 : 1 g/ml; MIC 90 : 8 g/ml) was higher than that of both antibiotics in this group. Among the macrolides, clarithromycin and azithromycin (MIC 50 : 8 g/ml and MIC 90 : 32 g/ml) were the most active macrolides, followed by erythromycin (MIC 50 : 16 g/ml; MIC 90 : 32 g/ml) and dirithromycin (MIC 50 and MIC 90 : 64 g/ml).
Discussion
When compared with previous studies, the strains examined in this study had higher MIC values for all drugs except doxycycline [7, 8] . This result may be due to the regional differences in the resistance rates of Brucella strains in Turkey, where brucellosis is an endemic disease. The considerably high MICs for macrolides are of specifi c importance. Although it is forbidden by the Ministry of Agriculture, some antibiotics (naracin, avoparcin, erythromycin and other macrolides) are found in animal feed [personal commun., Prof. Figen Kırkpınar, Ege University, Agriculture Faculty, Department of Animal Science]. This may explain the high resistance rates to macrolides among B. melitensis in our region. Inappropriate quinolone and macrolide usage is somewhat higher than that of tetracyclines in Turkey, hence the fact that all the strains were clinical isolates may also contribute to the higher macrolide and quinolone resistance [9] . The combination of doxycycline and rifampin is currently recommended by the World Health Organization for patients with acute brucellosis [10] , but the limited number of effective antibiotics, adverse effects, therapeutic failures and the necessity to use antimicrobials for long periods of time in patients with localized brucellosis have led to a search for new drugs to combat the disease. Quinolones are among the leading drugs for future potential therapeutic options. Quinolones are widely used in the treatment of brucellosis in our country because they possess excellent bioavailability after oral intake and achieve high concentrations in tissues, macrophages and leukocytes [11] . However, their reduced activity in acidic pH, the development of resistance in B. melitensis during ciprofl oxacin therapy and cross-resistance to other fl uoroquinolones made them unfavorable in brucellosis therapy in a short time [12, 13] .
In the present study, while the MIC 50 and MIC 90 values for ciprofl oxacin and levofl oxacin were similar (0.5 and 2 g/ml, respectively), the MIC 90 value for moxifl oxacin (8 g/ml) was twofold higher than those of the other quinolones, and these were signifi cantly higher than previously reported [8, 14] . Martin et al. [14] reported MIC 90 0.06 g/ml for sitafl oxacin against B. melitensis strains in vitro.
Although the value of MIC 90 for doxycycline (0.5 g/ ml) and ciprofl oxacin (2 g/ml) in this study is higher than (doxycycline: 0.064 g/ml and ceftriaxone: 0.25 g/ ml) that reported by Bodur et al. [8] , the magnitude of the values is approximately the same (fourfold).
Macrolides are generally perceived as safe and effective antibiotics, with good activity against Brucella spp. However, the MIC values of the isolates in this study were higher compared to those previously reported [15] [16] [17] . Of the four macrolides tested in this study, dirithromycin was the least active agent (64 g/ml), thereby supporting our previous in vivo fi ndings in a murine brucellosis model, in which dirithromycin had the lowest cure rate alone or in combination with rifampicin [18] . Doxycycline had the lowest MIC 90 value in our study. This fi nding is consistent with data reported in previous studies [8, 13, 19, 20] involving the cyclines.
Conclusion
The antimicrobial susceptibility of B. melitensis isolates in our region showed that the conventional agent doxycycline is more active than quinolones and macrolides. Our fi ndings further indicate that there is an increasing resistance among B. melitensis strains against macrolides and quinolones.
